Borowitz D, Durie PR, Clarke LL, Werlin SL, Taylor CJ, Semler J, De Lisle RC, Lewindon P, Lichtman SM, Sinaasappel M, Baker RD, Baker SS, Verkade HJ, Lowe ME, Stallings VA, Janghorbani M, Butler R, Heubi J: Gastrointestinal outcomes and confounders in cystic fibrosis. J Pediatr Gastroenterol Nutr. 2005, 41 (3): 273-285. 10.1097/01.mpg.0000178439.64675.8d.
Article
PubMed
Google Scholar
Smyth RL, Croft NM, O'Hea U, Marshall TG, Ferguson A: Intestinal inflammation in cystic fibrosis. Arch Dis Child. 2000, 82 (5): 394-399. 10.1136/adc.82.5.394.
Article
CAS
PubMed
PubMed Central
Google Scholar
Croft NM, Marshall TG, Ferguson A: Gut inflammation in children with cystic fibrosis on high-dose enzyme supplements. Lancet. 1995, 346 (8985): 1265-1267. 10.1016/S0140-6736(95)91864-7.
Article
CAS
PubMed
Google Scholar
Croft NM, Marshall TG, Ferguson A: Direct assessment of gastrointestinal inflammation and mucosal immunity in children with cystic fibrosis. Postgrad Med J. 1996, 72 (Suppl 2): S32-S36.
PubMed
Google Scholar
Werlin SL, Benuri-Silbiger I, Kerem E, Adler SN, Goldin E, Zimmerman J, Malka N, Cohen L, Armoni S, Yatzkan-Israelit Y, Bergwerk A, Aviram M, Bentur L, Mussaffi H, Bjarnasson I, Wilschanski M: Evidence of intestinal inflammation in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr. 2010, 51 (3): 304-308.
CAS
PubMed
Google Scholar
Fagerberg UL, Loof L, Lindholm J, Hansson LO, Finkel Y: Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2007, 45 (4): 414-420. 10.1097/MPG.0b013e31810e75a9.
Article
PubMed
Google Scholar
Summerton CB, Longlands MG, Wiener K, Shreeve DR: Faecal calprotectin: a marker of inflammation throughout the intestinal tract. Eur J Gastroenterol Hepatol. 2002, 14 (8): 841-845. 10.1097/00042737-200208000-00005.
Article
CAS
PubMed
Google Scholar
Canani RB, Terrin G, Rapacciuolo L, Miele E, Siani MC, Puzone C, Cosenza L, Staiano A, Troncone R: Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease. Dig Liver Dis. 2008, 40 (7): 547-553. 10.1016/j.dld.2008.01.017.
Article
PubMed
Google Scholar
Bruzzese E, Raia V, Gaudiello G, Polito G, Buccigrossi V, Formicola V, Guarino A: Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration. Aliment Pharmacol Ther. 2004, 20 (7): 813-819. 10.1111/j.1365-2036.2004.02174.x.
Article
CAS
PubMed
Google Scholar
Bunn SK, Michael Bisset W, Main MJC, Gray ES, Olson S, Golden BE: Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2001, 33 (1): 14-22. 10.1097/00005176-200107000-00003.
Article
CAS
PubMed
Google Scholar
Berni Canani R, Rapacciuolo L, Romano MT, Tanturri de Horatio L, Terrin G, Manguso F, Cirillo P, Paparo F, Troncone R: Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice. Dig Liver Dis. 2004, 36 (7): 467-470. 10.1016/j.dld.2004.02.009.
Article
CAS
PubMed
Google Scholar
Briars G: Intestinal inflammation in cystic fibrosis. Arch Dis Child. 2001, 84 (4): 374-375.
Article
CAS
PubMed
Google Scholar
Raia V, Maiuri L, De Ritis G, De Vizia B, Vacca L, Conte R, Auricchio S, Londei M: Evidence of chronic inflammation in morphologically normal small intestine of cystic fibrosis patients. Pediatr Res. 2000, 47 (3): 344-350. 10.1203/00006450-200003000-00010.
Article
CAS
PubMed
Google Scholar
Armstrong DS, Grimwood K, Carlin JB, Carzino R, Gutierrez JP, Hull J, Olinsky A, Phelan EM, Robertson CF, Phelan PD: Lower airway inflammation in infants and young children with cystic fibrosis. Am J Respir Crit Care Med. 1997, 156 (4 Pt 1): 1197-1204.
Article
CAS
PubMed
Google Scholar
Armstrong DS, Hook SM, Jamsen KM, Nixon GM, Carzino R, Carlin JB, Robertson CF, Grimwood K: Lower airway inflammation in infants with cystic fibrosis detected by newborn screening. Pediatr Pulmonol. 2005, 40 (6): 500-510. 10.1002/ppul.20294.
Article
PubMed
Google Scholar
Balough K, McCubbin M, Weinberger M, Smits W, Ahrens R, Fick R: The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis. Pediatr Pulmonol. 1995, 20 (2): 63-70. 10.1002/ppul.1950200203.
Article
CAS
PubMed
Google Scholar
Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DW: Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med. 1995, 151 (4): 1075-1082.
CAS
PubMed
Google Scholar
Bruzzese E, Raia V, Spagnuolo MI, Volpicelli M, De Marco G, Maiuri L, Guarino A: Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: a pilot study. Clin Nutr. 2007, 26 (3): 322-328. 10.1016/j.clnu.2007.01.004.
Article
PubMed
Google Scholar
FitzSimmons SC, Burkhart GA, Borowitz MD, Grand RJ, Hammerstrom T, Durie PR, Lloyd-Still JD, Lowenfels AB: High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. N Engl J Med. 1997, 336 (18): 1283-1289. 10.1056/NEJM199705013361803.
Article
CAS
PubMed
Google Scholar
Leclercq-Foucart J, Forget PP, van Cutsem JL: Lactulose-rhamnose intestinal permeability in children with cystic fibrosis. J Pediatr Gastroenterol Nutr. 1987, 6 (1): 66-70. 10.1097/00005176-198701000-00012.
Article
CAS
PubMed
Google Scholar
Golden BE, Clohessy PA, Russell G, Fagerhol MK: Calprotectin as a marker of inflammation in cystic fibrosis. Arch Dis Child. 1996, 74 (2): 136-139. 10.1136/adc.74.2.136.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gray RD, Imrie M, Boyd AC, Porteous D, Innes JA, Greening AP: Sputum and serum calprotectin are useful biomarkers during CF exacerbation. J Cyst Fibros. 2010, 9 (3): 193-198. 10.1016/j.jcf.2010.01.005.
Article
CAS
PubMed
Google Scholar
Fridge JL, Conrad C, Gerson L, Castillo RO, Cox K: Risk factors for small bowel bacterial overgrowth in cystic fibrosis. J Pediatr Gastroenterol Nutr. 2007, 44 (2): 212-218. 10.1097/MPG.0b013e31802c0ceb.
Article
PubMed
Google Scholar
Lisowska A, Madry E, Pogorzelski A, Szydlowski J, Radzikowski A, Walkowiak J: Small intestine bacterial overgrowth does not correspond to intestinal inflammation in cystic fibrosis. Scand J Clin Lab Invest. 2010, 70 (5): 322-326. 10.3109/00365513.2010.486869.
Article
CAS
PubMed
Google Scholar